Huang-Lian-Jie-Du decoction alleviates cognitive deficits in Alzheimer’s disease model 5xFAD mice by inhibiting Trem2/Dap12 signaling pathway
Chinese Medicine,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: April 15, 2025
Abstract
Background
Alzheimer’s
disease
(AD)
is
a
progressive
neurodegenerative
disorder
predominantly
affecting
the
elderly
population.
It
characterized
by
cognitive
deficits
associated
with
accumulation
of
amyloid-beta
plaques
and
neurofibrillary
tangles.
Huang-Lian-Jie-Du
(HLJD)
decoction,
recognized
as
representative
formulation
heat-clearing
detoxification
effects,
has
been
demonstrated
to
be
effective
in
treating
AD.
However,
underlying
mechanisms
require
further
investigation.
Methods
5xFAD
mice
were
administrated
low
high
doses
HLJD.
The
Morris
water
maze
test
was
conducted
assess
effects
Aβ42
total
tau
protein
levels
evaluated.
Additionally,
network
pharmacology
analysis
performed
identify
therapeutic
targets
HLJD’s
active
components
their
relevance
ELISA,
qPCR,
Western
Blot,
immunofluorescence
assays
employed
confirm
identified
pathways.
Finally,
primary
microglia
isolated
from
used
validate
candidate
Results
HLJD
improved
reduced
amyloid
plaque
deposition
levels.
Network
indicated
that
influences
neuroinflammatory
response,
particularly
through
Dap12
signaling
pathway.
This
confirmed
neuroinflammation
markers,
including
TNF-α,
IL-1β,
IL-6,
indicators
microglial
activation
polarization.
expression
Trem2
hippocampus
(HIP)
mice,
well
microglia,
downregulated
following
treatment.
Conclusion
Our
study
indicates
alleviates
AD
suppressing
Trem2/Dap12
pathway
HIP
thereby
inhibiting
neuroinflammation.
Graphical
Language: Английский
Diabetes and brain: omics approaches to study diabetic encephalopathy
Nicoletta Lionetti,
No information about this author
M LAGO,
No information about this author
T Brescia
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
16
Published: May 12, 2025
Diabetes
mellitus
(DM)
is
a
complex
metabolic
disorder
associated
with
many
complications,
including
diabetic
encephalopathy
(DE).
DE
severe
neurological
condition
characterized
by
progressive
decline
in
cognitive
and
motor
functions,
significantly
impacting
patients’
quality
of
life.
Despite
advancements
understanding
DM,
the
intricate
pathogenetic
mechanisms
underlying
remain
incompletely
elucidated.
This
review
comprehensively
analyzes
application
omics
technologies
to
decipher
molecular
basis
identify
potential
diagnostic
biomarkers
therapeutic
targets.
Several
studies
on
animal
models
have
revealed
specific
signatures
changes
gene
expression
key
memory
brain
regions,
like
hippocampus,
highlighting
We
explore
how
these
“omics”
approaches
provided
novel
insights
into
interplay
factors
contributing
DE.
Recurrent
alterations
were
identified
upon
evaluation
analysis
from
human
tissues
vitro
Findings
indicate
that
this
pathological
impaired
energy
metabolism,
oxidative
stress,
neuroinflammation,
neuroendocrine
dysfunction
influence
gut
microbiota.
A
multi-omics
approach,
integrating
data
various
limited
studies,
enhances
translational
pathogenesis,
new
implications
for
diagnosis
treatment.
Language: Английский